Search

everythinglearnresearchcommunity

for

Search:↓

Early baldness in men may indicate risks for obesity, metabolic syndrome, insulin resistance, and heart disease, similar to women with PCOS. Alopecia areata is often linked with autoimmune diseases and mental health issues. Certain hair disorders are due to genetic issues, and chemotherapy can cause hair loss through specific biological pathways. Iron deficiency's link to hair loss is still disputed.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

Plant-based compounds can improve wound dressings and skin medication delivery.

Managing multiple autoimmune diseases in one patient is very challenging.

Nanotechnology shows promise for better chronic wound healing but needs more research.

Adding a second method to PROTACs could improve cancer treatment.

New materials that better mimic natural skin structure could improve healing, especially for chronic wounds.

Human hair follicles may provide a noninvasive way to diagnose diseases and have potential in regenerative medicine.

The document concludes that diagnosing female hair loss requires careful examination, with treatments varying by condition and psychological support often necessary.

Primary care is key in managing PCOS, focusing on lifestyle changes and medications like birth control and metformin.

Keratin from hair binds well to gold and BMP-2, useful for bone repair.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Psoriasis treatments don't raise severe COVID-19 risk, except for acitretin.

The document concludes that there have been significant advances in the treatment and diagnosis of various skin conditions.

Stem cell therapies show potential for treating hair loss with fewer side effects.

Platelet-derived bio-products help in wound healing and tissue regeneration but lack standardized methods, and their use in medicine is growing.

Genetic discoveries are leading to new treatments for alopecia areata.

Melatonin could be an effective treatment for Alzheimer's Disease and rosacea.

Acyzol could help treat conditions caused by zinc deficiency.

Some common medications may harm male fertility by affecting hormones, sperm production, and sexual function.

Exosome treatment for hair growth is promising but not FDA-approved and needs more research on safety and how it works.

5-alpha reductase inhibitors, like finasteride and dutasteride, are used for prostate issues, hair loss, and excessive hair growth, may help with COVID-19, but can cause sexual and mental health side effects, and their use in preventing prostate cancer needs more examination.

Cannabinoids like CBD and THC may help treat non-cancer skin diseases, but more research is needed.

A medication for skin rash also unexpectedly treated hair loss in a patient.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.

Isotretinoin is effective for treating dissecting cellulitis, but recurrence is common.

CB-03-01 is a promising skin cream for treating hormone-related skin problems without causing harmful body-wide effects.

Consider benefits and risks of new alopecia treatments for safety.

Finasteride reduces prostate cancer risk but may increase high-grade cancer chances.